Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
NVO Novo Nordisk A/S daily Stock Chart
Novo Nordisk A/S
Index- P/E30.66 EPS (ttm)1.80 Insider Own- Shs Outstand2.02B Perf Week3.31%
Market Cap111.70B Forward P/E24.37 EPS next Y2.27 Insider Trans- Shs Float1.42B Perf Month1.62%
Income4.70B PEG1.93 EPS next Q0.46 Inst Own10.30% Short Float0.28% Perf Quarter2.87%
Sales14.89B P/S7.50 EPS this Y7.80% Inst Trans-0.09% Short Ratio2.97 Perf Half Y0.13%
Book/sh2.28 P/B24.21 EPS next Y13.82% ROA40.70% Target Price71.10 Perf Year19.06%
Cash/sh0.88 P/C62.68 EPS next 5Y15.90% ROE83.60% 52W Range41.08 - 60.34 Perf YTD32.46%
Dividend0.73 P/FCF41.04 EPS past 5Y23.00% ROI65.50% 52W High-8.53% Beta1.00
Dividend %1.32% Quick Ratio0.90 Sales past 5Y11.70% Gross Margin84.70% 52W Low34.36% ATR1.27
Employees39658 Current Ratio1.20 Sales Q/Q25.10% Oper. Margin42.10% RSI (14)47.65 Volatility1.97% 2.02%
OptionableYes Debt/Eq0.02 EPS Q/Q22.50% Profit Margin31.60% Rel Volume1.26 Prev Close55.25
ShortableYes LT Debt/Eq0.00 EarningsOct 29 BMO Payout42.70% Avg Volume1.35M Price55.19
Recom1.00 SMA20-0.54% SMA50-2.13% SMA2005.24% Volume1,695,683 Change-0.11%
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Feb-26-08Downgrade Bear Stearns Outperform → Peer Perform
Oct-01-15 05:46PM  Celsion Begins Patient Enrollment in Ovarian Cancer Study
10:00AM  Xybion announces that Novo Nordisk selects Pristima to manage pharmacology research studies across all research sites PR Newswire
Sep-30-15 05:38PM  Why Novo Nordisk Is All in on New Diabetes Drug at TheStreet
05:35PM  Roche Presents Positive Data on Respiratory Drug Esbriet
03:49PM  Novo Nordisk Betting on New Long-Lasting Diabetes Drug to Dominate at TheStreet
Sep-28-15 04:30PM  Novo Nordisk's Tresiba & Ryzodeg Gain Entry into the U.S.
11:58AM  This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move at Insider Monkey
08:50AM  Is Novo Nordisk (NVO) Stock a Solid Choice Right Now?
04:22AM  Novo shares jump ahead of its largest ever drug launch Reuters
Sep-25-15 06:17PM  FDA approves 2 diabetes drugs from Novo Nordisk
05:03PM  FDA Clears Novo Nordisk Diabetes Drug at The Wall Street Journal
03:45PM  FDA approves Novo Nordisk's long-awaited diabetes drug Reuters
09:34AM  5 Toxic Stocks to Sell Now at TheStreet
Sep-23-15 03:06PM  How Pricing Affected Sanofis Diabetes Franchise in 2Q15
Sep-22-15 03:01PM  Enactment Of Clinton Prescription Drug Plan Will Result In R&D Job Losses at Forbes
09:11AM  Novo Nordisk to build ?70m plant in Iran at Financial Times
04:39AM  Novo Nordisk to build manufacturing plant in Iran AFP
Sep-21-15 12:07PM  European stocks rebound from worst drop in 2 weeks at MarketWatch
Sep-17-15 06:02PM  Novo Nordisk's Victoza Fares Better than Sanofi's Lyxumia
Sep-16-15 08:47AM  Novo to Probe One of Its Diabetes Drugs for Fatty Liver Disease at Bloomberg
12:00AM  Banking on Diabetes Epidemic, This Drugmaker Sits Out M&A Craze at Bloomberg
Sep-15-15 09:44AM  Analysts bet Novo's insulin drug will get U.S. green light Reuters
Sep-14-15 12:50PM  Jim Simons and Ken Fisher Decrease Exposure on Novo Nordisk A/S Gurufocus
Sep-09-15 07:29AM  Novo Nordisk (NVO) Sees Hammer Chart Pattern: Time to Buy?
Sep-08-15 06:23PM  Can Top Drugmaker Keep Boosting Sales, Stock Price? at Investor's Business Daily
Sep-03-15 04:40PM  Bristol-Myers' (BMY) Opdivo Gets Priority Review, Shares Up
06:15AM  Research and Markets: China Insulin Detemir (Novo Nordisk) Market Report 2010-2019 Business Wire
Sep-02-15 04:30PM  Bristol-Myers/AbbVie Cancer Drug Gets Priority Review
Aug-31-15 08:47AM  Is Novo Nordisk (NVO) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat
Aug-28-15 10:25AM  Now the work starts for Novo Nordisk in Clayton at
09:50AM  Research and Markets: China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk Business Wire
06:29AM  Coverage initiated on Novo Nordisk A/S by Leerink Partners
Aug-27-15 03:30PM  Novo Nordisk to Start PIONEER Program on Semaglutide
07:17AM  Effective obesity management: It's more than reducing numbers on the scale PR Newswire
07:17AM  Effective obesity management: It's more than reducing numbers on the scale CNW Group
Aug-26-15 02:13PM  Novo Nordisk adding diabetes drug output in NC, Denmark
01:50PM  Nearly 700 N.C. jobs announced as part of $1.2B Novo Nordisk expansion at
09:38AM  Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1 GlobeNewswire
Aug-24-15 01:40PM  Novo Nordisk A/S Q2 Earnings Analysis: By the Numbers, 2015
Aug-14-15 03:21PM  Jim Simons Betting On Microsoft, Colgate-Palmolive, Novo Nordisk & Alaska Air
09:43AM  Novo May Benefit From Possible Shire-Baxalta Disruption at Bloomberg
04:58AM  Biggest Insulin Maker May Build Next Diabetes Drug Plant in U.S. at Bloomberg
Aug-11-15 04:13AM  Moody's: Accelerated growth expected for EMEA Pharmaceuticals in 2016 at Moody's
Aug-07-15 06:23PM  Novo Nordisk's Net Income Up Y/Y, 2015 Outlook Maintained - Analyst Blog
Aug-06-15 08:16AM  We want to be seen as Chinese: Novo Nordisk at CNBC
07:42AM  China gets tougher for Western drugmakers
07:06AM  Novo Nordisk points to tough China market at Financial Times
07:06AM  Novo Nordisk points to tough China market
05:45AM  Research and Markets: Investigation Report on China's Liraglutide Market, 2011-2019 Featuring Novo Nordisk Business Wire
Aug-05-15 09:12AM  4 Pharmaceutical Stocks to Buy in Wake of Shire-Baxalta Bid at TheStreet
Jul-30-15 06:23PM  Six International Leaders Preparing To Report Results at Investor's Business Daily
Jul-24-15 11:12AM  AbbVie: Beware the Biosimilars? at
10:14AM  Appointment Notice - Novo Nordisk Canada Inc. PR Newswire
10:14AM  Appointment Notice - Novo Nordisk Canada Inc. CNW Group
Jul-16-15 12:18PM  Novo Nordisk says Flexpro PenMate gets FDA approval Reuters
Jul-15-15 09:48AM  Greece Is On The Verge Of A Health Catastrophe at Forbes
Jul-13-15 01:50PM  Novo Nordisk Up on Positive Results from Diabetes Study - Analyst Blog
Jul-10-15 12:59PM  Novo Nordisk's new GLP-1 diabetes drug hits goal in trial +5.31%
Jul-07-15 03:50PM  Versartis (VSAR) Up on Partial Hold Lift on Lead Candidate - Analyst Blog
01:04PM  Is This Novo Nordisk's Next Blockbuster Drug? at Motley Fool
Jul-02-15 12:00PM  Novo Nordisk Halts Sale of Tresiba Insulin in Germany Over Pricing Dispute at The Wall Street Journal
Jul-01-15 12:15PM  The Greek debt crisis turned these European stocks into even better buys at Fortune
09:24AM  Status regarding Novo Nordisk's holding of its own shares (30 June 2015) Thomson Reuters ONE
Jun-29-15 04:45PM  Novartis' Cosentyx Positive in Psoriatic Arthritis Study - Analyst Blog
Jun-25-15 11:17AM  Conquering Hemophilia: Novo Nordisk Reports Encouraging Data From Phase III Trial Of NovoEight
Jun-24-15 06:15PM  Cramer: Getting down to BAX's Biz
Jun-22-15 03:17PM  Top Europe Stocks Rally On Greece Bailout Hopes at Investor's Business Daily
Jun-17-15 08:21PM  Edited Transcript of NOVO B.CO corporate analyst meeting
Jun-08-15 03:35PM  Novo Nordisk Reveals New Findings from Additional Studies - Analyst Blog
Jun-07-15 08:00AM  Novo Nordisk type 2 diabetes combo drug tops Sanofi's Lantus -study
03:00AM  New Xultophy® (IDegLira) Phase 3b Study Showed Statistically Significant HbA1c Reduction, Body Weight Change and Lower Rate of Hypoglycaemia Versus Insulin Glargine CNW Group
May-28-15 10:06AM  19 kids and cancelled: TV shows that got pulled due to controversy at Fortune
May-27-15 07:05PM  Is This Diabetes Stock a Better Bet Than MannKind? at Investopedia
May-25-15 12:50PM  Novo Nordisk's Saxenda Delays Onset of Type II Diabetes - Analyst Blog
May-20-15 12:08PM  Novo Nordisk, Baxter clash over haemophilia drug patent Reuters
10:52AM  Novo Nordisk rejects Baxter patent claim over Novoeight Reuters
10:40AM  China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient Compliant Technologies Especially for Insulin Pump and CGM PR Newswire
May-18-15 04:59PM  SLU vs. Bothell: The region's two hot biotech real estate markets go head to head at
May-17-15 11:36AM  Billionaire Jim Simons Top Holdings: Inc. (AMZN), Colgate-Palmolive Company and More at Insider Monkey
May-14-15 09:35AM  UnitedHealth Group (UNH), Novo Nordisk (NVO), Johnson & Johnson (JNJ): Cheapest Healthcare Stocks Picked By Markel Gayner at Insider Monkey
May-08-15 04:21PM  Healthcare Winners and Losers: May 8, 2015
May-06-15 06:00AM  Hot Drugs Show Sharp Price Hikes in Shadow Market
06:00AM  Diabetes Drugs Compete With Prices That Rise in Lockstep at Bloomberg
May-05-15 01:16PM  Healthcare Mid-Day Winners and Losers: May 05, 2015
12:51PM  Healthcare AM Winners and Losers: May 05, 2015
12:46PM  Healthcare AM Winners and Losers: May 04, 2015
12:46PM  Healthcare Mid-Day Winners and Losers: May 04, 2015
12:46PM  Healthcare Winners and Losers: May 04, 2015
May-04-15 03:41PM  Novo Nordisk (NVO) Beats on Q1 Earnings, Updates Outlook - Analyst Blog
May-03-15 11:28PM  Weekly 52-Week Highs Highlight: ALTR, AIG, LUX, NVO, EXPE
01:26PM  5 Trade Ideas for Monday: Fastenal, Goodyear, Northern Trust, Novo Nordisk & NXP Semi
Apr-30-15 06:50PM  Gilead EPS Spikes On Harvoni Drug, Latest HCV Fighter
10:48AM  Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings at Investor's Business Daily
07:08AM  European drugmakers lifted by weak euro at Financial Times
Apr-22-15 11:44AM  Economic Sentiment up in the Eurozone: EWG up 0.88%, FEZ up 0.46%
11:27AM  Novo launches Saxenda in US, sees more launches in 2015 Reuters
10:38AM  Novo Nordisk says Saxenda obesity drug to cost $1,068 per month
09:23AM  3 Large-Cap Pharmaceutical Companies to Invest in Right Now at TheStreet
Apr-13-15 05:09PM  Arena, Eisai Finish Phase I Studies on Obesity Drug Belviq - Analyst Blog
Apr-09-15 01:40PM  Novo Nordisk's Tresiba & Ryzodeg NDAs under FDA Review - Analyst Blog
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S has a collaboration agreement with the Langer Laboratory for the development of next-generation drug delivery devices. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.